Encrypted within dietary proteins are sequences released by digestion or fermentation that show biological activity in vitro, though the gap to physiological relevance remains wide.
Key Takeaways
- Casein, whey, soy, and marine proteins all contain sequences that become active once released by enzymatic hydrolysis, fermentation, or gastrointestinal digestion.
- A released peptide must survive further digestion, cross the intestinal epithelium, and reach its target at sufficient concentration.
- Ask whether the intact peptide has been measured in human plasma after oral intake.
Where they come from
Casein, whey, soy, and marine proteins all contain sequences that become active once released by enzymatic hydrolysis, fermentation, or gastrointestinal digestion. The parent proteins are inactive with respect to these activities, which is why the field describes the peptides as encrypted.
Activity classes studied
The most frequently reported activities are angiotensin-converting enzyme inhibition, antioxidant behaviour, opioid-like activity, and mineral binding. Almost all of this evidence comes from in vitro assays rather than from controlled human outcomes.
For related mechanism work, see bacteriocin peptides.
The bioavailability problem
A released peptide must survive further digestion, cross the intestinal epithelium, and reach its target at sufficient concentration. Most food-derived peptides are degraded before this happens, which is the central objection to extrapolating from assay data.
Evidence quality varies
Some lactotripeptides have accumulated a reasonable body of human blood-pressure data, while most other sequences rest on assay results alone. Treating all food-derived peptides as equivalent is a significant error in the secondary literature.
How to evaluate claims
Ask whether the intact peptide has been measured in human plasma after oral intake. If the answer is no, the activity claim describes what the peptide does in a dish rather than what it does in a person.
Experimental Conditions and Practical Setup
The decisive experiment is measuring the intact peptide in plasma after oral administration, because activity in an assay says nothing about whether the sequence survives digestion and absorption. Where this measurement has been done, intact fragments are detected at low concentrations and for a limited window, which frames how the activity data should be read.
Evidence classes in food peptide research
| Evidence | What it supports | Weight |
|---|---|---|
| Enzyme inhibition assay | Mechanism in vitro | Hypothesis generating only |
| Cell-based assay | Effect on cells | Better, still concentration dependent |
| Plasma detection after dosing | Absorption of intact peptide | Necessary but not sufficient |
| Controlled human endpoint | Physiological effect | The only decisive evidence |
Practical Notes for the Bench
- Ask whether intact peptide has been measured in human plasma.
- Separate the few sequences with human data from the many with only assay data.
- Account for further digestion when extrapolating from in vitro activity.
Frequently Asked Questions
Are food-derived peptides active in the body?
Some are, but most evidence is from in vitro assays, and many sequences are degraded during digestion before absorption.
Which have human evidence?
Certain lactotripeptides have a reasonable human blood-pressure literature; most other examples do not.
Why are the parent proteins inactive?
Because the active sequence is encrypted within the protein structure and only becomes available after hydrolysis.
Why is so much food peptide research not clinically relevant?
Because assay concentrations typically exceed anything reached in tissue, and peptides are diluted, degraded, and protein-bound after ingestion.
Related Reading
- bacteriocin peptides
- antihypertensive peptides
- exorphin opioid peptides
- peptide synthesis scale-up
- nasal peptide delivery
References & Further Reading
- Singh BP et al. In silico and molecular docking approaches in food-derived bioactive peptide discovery: Trends, challenges, and prospects. Food Res Int. 2025. PubMed 41267250
- Nong NTP et al. Characteristics of Food Protein-Derived Antidiabetic Bioactive Peptides: A Literature Update. Int J Mol Sci. 2021. PubMed 34502417
- Mehmood A et al. Food-derived bioactive peptides with anti-hyperuricemic activity: A comprehensive review. Food Chem. 2024. PubMed 38678657
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- Peptide research collection at Nature
Content here is written for researchers handling peptide reagents. It does not constitute medical guidance, dosing advice, or an endorsement of any supplier.
Reviewed by Dr. Aiko Tanaka, Bioactive Peptides & Dermatological Research.